Projects

“Silent Signals: miRNAs as Early Novel Predictors of Cardiovascular Disease Risk in Metabolic Syndrome"

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2025

Project Lead

Dr. Ashwini Priyanka

Authors

Ashwini Priyanka V 1, Rebecca Raj kurian2 , Madhumathi G Nair3 , Sonali Appaiah4

Project Status

ongoing

Project Type

Original